E I Chukanova Selected Research

emoxypine succinate

1/2021	[Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
1/2021	[The efficacy of antioxidant treatment with mexidol forte in 250 patients with chronic cerebral venous insufficiency].
1/2019	[Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
1/2015	[The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E I Chukanova Research Topics

Disease

5	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2005
5	Stroke (Strokes) 01/2016 - 01/2005
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2009 - 01/2005
2	Venous Insufficiency 01/2021 - 01/2016
2	Brain Diseases (Brain Disorder) 01/2009 - 01/2001
1	Ischemia 01/2019
1	Atherosclerosis 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Hypersensitivity (Allergy) 01/2015
1	Disease Progression 01/2007
1	Transient Ischemic Attack 01/2007

Drug/Important Bio-Agent (IBA)

4	emoxypine succinateIBA 01/2021 - 01/2015
2	TabletsIBA 01/2021 - 01/2019
2	Lysine (L-Lysine)FDA Link 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2015
2	Thioctic Acid (Lipoic Acid)IBA 01/2018 - 01/2001
2	vinpocetineIBA 01/2009 - 01/2009
1	AntioxidantsIBA 01/2021
1	Diosmin (Daflon)IBA 01/2021
1	SolutionsIBA 01/2021
1	HesperidinIBA 01/2021
1	NAD (NADH)IBA 01/2018
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2016
1	agomelatine (S20098)IBA 01/2011
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2009
1	ActihaemylIBA 01/2007
1	cerebrolysinIBA 01/2005
1	Pro-Gly-Pro- ACTH (4-7)IBA 01/2005

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2007
1	Oral Administration 01/2019
1	Secondary Prevention 01/2016